DAFTAR PUSTAKA

1. Riset Kesehatan Dasar (Riskesdas) (2018). Badan Penelitian dan

Pengembangan Kesehatan Kementerian RI tahun 2018.
http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_20
18/Hasil%20Riskesdas%202018.pdf – Diakses Agustus 2018.
2. GLOBOCAN (2018). Incidence, Mortality, and Prevalence by Cancer Site
Worldwide in 2018. http://gco.iarc.fr/today/data/factsheets/populations/900-
world-fact-sheets.pdf - Diakses Agustus 2018.
3. American Cancer Society (2018). Cancer Facts and Figures 2018.
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-
statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-
2018.pdf - Diakses Agustus 2018.
4. GLOBOCAN (2018). Incidence, Mortality, and Prevalence by Cancer Site
Indonesian in 2018. http://gco.iarc.fr/today/data/factsheets/populations/360-
indonesia-fact-sheets.pdf - Diakses Agustus 2018.
5. RSUP. Kejadian Karsinoma Buli-Buli Tahun 2013. Padang. Medical Record
RSUP Dr. M. Djamil 2013.
6. Iscan H, Efmansyah D, Alvarino. Carsinoma Buli-buli yang Dirawat dibangsal
Bedah RSUP Dr. M. Djamil Padang Tahun 2000 sampai 2005 [tesis]. Padang:
Fakultas Kedokteran Universitas Andalas;2006.
7. Umbas R, Safriadi F, Mochtar CA, Djatisoesanto W, Hamid ARAH. Urologic
cancer in Indonesia. Japanese Journal of Clinical Oncology. 2015;45(8):708–
12.
8. Rose TL, Deal AM, Nielsen ME, Smith AB, Milowsky MI. Sex disparities in
use of chemotherapy and survival in patients with advanced bladder cancer.
Wiley Online Library. 2016;122(13):2012-20.
9. Lin N, Wu WP, Lin YZ, Tao X, Chen SH, Ke ZB, et al. Risk factors for upper
tract urothelial reccurence following local excision of bladder cancer. Wiley
Cancer Medicine. 2018;7(8):4098-4103.
10. Tanagho EA. General Urology. 18th ed. San Fransisco. McGraw-Hill. 2013.

Fakultas Kedokteran Universitas Andalas 47

11. Yu Z, Yue W, Jiuzhi L,Youtao J, Guofei Z, Wenbin G. The risk of bladder
cancer in patient with urinary calculi: a Metaanalysis. Springer-Verlag GmbH
Germany. 2018;1-7.
12. American Cancer Society (2018). Cancer Facts and Figures 2018.
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-
statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-
2018.pdf - Diakses Agustus 2018.
13. Shih CJ, Chen YT, Ou SM, Yang WC, Chen TJ, Tarng DC. Urinary calculi and
risk of cancer. Wolters Kluwer Health. 2014;90(29): 1-8.
14. Budiono H, Soetojo. Incidence of bladder stone revised stone analysis and
pathology January 2006 – December 2010 period at Dr. Soetomo Hospital.
Jurnal Urologi Universitas Airlangga. 2014;2(2): 1-16.
15. Lokeshwar SD, Klaassen Z, Terris MK. A contemporary review of risk factors
for bladder cancer. Clin Oncol. 2016;1(1121):1-3.
16. Messing EM. Urothelial Tumor of the Bladder. In: Wein AJ, Kavoussi LR,
Novick AC, Partin AW, Peters CA 9eds). Campbell Walsh Urology. 9 th ed.
Philadelphia: Sounders Elsevier; 2007.p2407-46.
17. Witjes JA, Compe´rat E, Cowan NC, Santis MD, Gakis G, Lebret T, et al. EAU
guidelines on muscle-invasive and metastatic bladder cancer. European
Association of Urology. 2015;65:778–92.
18. Basuki B. Purnomo. Dasar-Dasar Urologi. 3rd ed. Jakarta: CV. Sagung Seto,
2016.
19. Eroschenko VP. Atlas histologi difiore dengan korelasi fungsional. Jakarta:
EGC. 2015.
20. Zamzami Z. Penatalaksanaan terkini batu saluran kencing di RSUD Arifin
Achmad Pekanbaru, Indonesia. Jurnal Kesehatan Melayu. 2018;1(2):60-6
21. Sulistiyowati R, Setiani O, Nurjazuli. Faktor risiko yang berhubungan dengan
kejadian kristal batu saluran kemih di Desa Mrisi Kecamatan Tanggungharjo
Kabupaten Grobogan. Jurnal Kesehata Lingkungan Indonesia. 2013;12(2):99-
105.
22. Tubagus YE, Ali RH, Rondo AG. Gambaran CT-Scan tanpa kontras pada
pasien dengan batu saluran kemih di bagian radiologi FK Unsrat/SMF

Fakultas Kedokteran Universitas Andalas 48

 Radiologi RSUP Prof. Dr. R. D. Kandou Manado periode Juli 2016 - Juni 2017.
Jurnal e-Clinic (eCl). 2017;5(2):262-6.
23. Duvdevani M, Sfoungaristos S, Bensalah K, Peyronnet B, Krambeck A, Khadji
S, et al. Stones in special situations. World Journal of Urology.
2017;35(9):1381-93.
24. Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of
urolithiasis in Asia. Asian Journal of Urology. 2018:1-22.
25. Negri AL, Spivacow FR, Valle EED, Forrester M, Rosende G, Pinduli I. Role
of overweight and obesity on the urinary excretion of promoters and inhibitors
of stone formation in stone formers. Urological Research. 2008;36(6):303-7.
26. Noviandrini E, Birowo P, Rasyid N. Urinary stone characteristics of patients
treated with extracorporeal shock wave lithotripsy in Cipto Mangunkusumo
Hospital Jakarta, 2008–2014: a gender analysis. Medical Journal of Indonesia.
2015;24(4):234-8.
27. Friedlander JI, Antonelli JA, Pearle MS. Diet: from food to stone. World
Journal of Urology. 2014;33(2):179–85.
28. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, et al. Metabolic
evaluation and recurrence prevention for urinary stone patients: EAU
Guidelines. European Urology. 2014;67(4):750-63.
29. Chen D, Zhang Y, Huang J, Liang X, Zeng T, Lan C, et al. The analysis of
microbial spectrum and antibiotic resistance of uropathogens isolated from
patients with urinary stones. Int J Clin Pract. 2018;72(6):1-9.
30. Ikatan Ahli Urologi Indonesia. Guidelines Batu Saluran Kemih. IAUI. 2007.
31. Bergamin PA, Kiosoglus AJ. Surgical management of reccurant urinary tract
infections: a review. Translational Andrology and Urology. 2017;6(2):153-62.
32. Cicione A, Nunzio CD, Manno S, Damiano R, Posti A, Lima E, et al. Bladder
stone management: an update. Minerva Urologica e Nefrologica.
2018;70(1);53-65.
33. Syafaah AN, Maulani H, Suciati T. Angka kejadian karsinoma urotheial di
bagian Patologi Anatomi RSUP dr. Mohammad Hoesin Palembang periode
tahun 2009-2013 [skripsi]. Palembang: Fakultas Kedokteran Univeristas
Sriwijaya;2015.

Fakultas Kedokteran Universitas Andalas 49

34. Pietzak EJ, Mucksavage P, Guzzo TJ, Malkowicz B. Heavy cigarette smoking
and aggressive bladder cancer at initial presentation. Elsevier. 2015;86(5):968-
73.
35. Ikatan Ahli Urologi Indonesia. Pedoman Penanganan Kanker Kandung Kemih
Tipe Urotelial. IAUI. 2014.
36. Carreon T, Hein MJ, Hanley KW, Viet SM, Ruder AM. Bladder cancer
incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a
rubber chemical manufacturing plant. Occupational and Environmental
Medicine. 2013;71(3):175-82.
37. Oberoi S, Barchowsky A, Wu F. The global burden of disease for skin, lung,
and bladder cancer caused by arsenic in food. Cancer Epidemiology Biomarkers
& Prevention. 2014;23(7):1187-94.
38. Zhong M, Gersbach E, Rohan SM, Yang XJ. Primary adenocarcinoma of the
urinary bladder: differential diagnosis and clinical relevance. Archives of
Pathology & Laboratory Medicine. 2013;137(3):371–81.
39. Supit W, Mochtar CA, Sugiono M, Umbas R. Survival of patients with
transitional cell carsinoma of the urinary bladder in Indonesia: a Single
Institution Review. Asian Pacific J Cancer Prev. 2011;12(2):549-53.
40. Teng CJ, Huon LK, Hu YW, Yeh MC, Chao Y, Yang MH, et al. Secondary
primary malignancy risk in patients with cervical cancer in Taiwan. Medicine.
2015;94(43):1-7.
41. Abern MR, Dude AM, Tsivian M, Coogan CL. The characteristics of bladder
cancer after radiotherapy for prostat cancer. Urologic Oncology.
2013;31(8):1628-34.
42. Babjuk M, Bohle A, Burger M, Comperat E, Kaasinen E, Palou J, et al.
Guidelines on non muscle invasive bladder cancer. European Association of
Urology. 2017.
43. Merseburger AS, Kuczyk MA. Urology at a Glance. 1 st. ed. Moul JW, editor.
Berlin: Springer, 2014. 151 p.
44. Moon A, Voet HV, Cresswell J. Management of muscle invasive bladder
cancer. Trends in Urology & Mens’s Health. 2015;6(6):7-11.

Fakultas Kedokteran Universitas Andalas 50

45. Reynard J, Brewster S, Biers S. Oxford Handbook of Urology. 3 rd. ed. New
York: Oxfor University Press, 2013. 264 p.
46. Duplisea JJ, Masson RJ, Reichard CA, Li R, Shen Y, Boorjian SA, et al. Trends
and disparities in the use of neoadjuvant chemotherapy for muscle-invasive
urothelial carcinoma. Canadian Urological Association Journal. 2018;13(2):1-
11.
47. Tang DH, Chang SS. Management of carcinoma in situ of the bladder: best
practice and recent developments. Therapeutic Advances in Urology.
2015;7(6):351–64.
48. Monn M F, Kaimakliotis HZ, Pedrosa JA, Cary KC, Bihrle R, Cheng L, et al.
Contemporary Bladder Cancer: Variant Histology May be a Significant Driver
of Disease. Elsevier. 2014;33(1):1-15.
49. Hsieh MC, Sung MT, Chiang PH, Huang CH, Tang Y, Su YL. The prognostic
impact of histopathological variants in patients with advanced urothelial
carcinoma. Plos One. 2015;10(6):1-11.
50. Makino T, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Naito R, et al.
Significance of perioperative chemotherapy in squamous cell carcinoma of the
upper and lower urinary tract. Anticancer Research. 2018;38:2241-5.
51. Fernando MH, Jayarajah U, Herath KB, De Silva MVC, Goonewardena SAS.
Aggressive squamous cell carcinoma of the bladder associated with a history of
large bladder stone - a case report. Clinical Case Reports. 2017;5(10):1616–9
52. Park S, Reuter VE, Hansel DE. Non-urothelial carcinomas of the bladder.
Histopathology. 2018;74(1):97–111.
53. Arslan B, Bozkurt I, Yonguc T, Vardar E, Degirmenci T, et al. Clinical features
and outcomes of nontransitional cell carcinomas of the urinary bladder:
Analysis of 125 cases. Urology Annals. 2015;7(2):177-83.
54. Warrick JI, Sjödahl G, Kaag M, Raman JD, Merrill S, et al. Intratumoral
heterogeneity of bladder cancer by molecular subtypes and histologic variants.
European Urology. 2018.
55. Buisan O, Orsola A, Oliveira M, Martinez R, Etxaniz O, et al. Role of
inflammation in the perioperative management of urothelial bladder cancer with
squamous-cell features: impact of neutrophil-to-lymphocyte ratio on outcomes

Fakultas Kedokteran Universitas Andalas 51

 and response to neoadjuvant chemotherapy. Clinical Genitourinary Cancer.
2017;15(4):697-706.
56. Molitor M, Junker K, Eltze E, Toma M, Denzinger S, et al. Comparison of
structural genetics of non-schistosoma-associated squamous cell carcinoma of
the urinary bladder.Int J Clin Exp Pathol. 2015;8(7):8143-58.
57. Milman H.A. Possible contribution of indomethacin to the carcinogenicity of
nongenotoxic bladder carcinogens that cause bladder calculi. Drug and
Chemical Toxicology. 2007;30(3):161–6.
58. Wang H, Wang Y, Kota KK, Sun B, Kallakury B, et al. Strong associations
between chromosomal aberrations in blood lymphocytes and the risk of
urothelial and squamous cell carcinoma of the bladder. Scientific Reports. 2017;
7(1):1598-607.
59. Abdel RO. Squamous Cell Carcinoma of the Bladder: A SEER Database
Analysis. Clinical Genitourinary Cancer. 2017;15(3):463-8.
60. Lopez BA, Henriques V, Montironi R, Cimadamore A, Raspollini MR, et al.
Variants and new entities of bladder cancer. Histopathology. 2018;74(1):77–96.

Fakultas Kedokteran Universitas Andalas 52